American Funds®

GROWTH FUNDS

®

476 Total Holdings:
As of 3/31/15 (updated quarterly, upon availability).
All Holdings: 1 - 15 of 476
Asset Type
Novo Nordisk A/S, Class B Equity 99,131,991 $5,304,212,079.00 4.13%
Bayer AG Equity 21,295,666 $3,199,784,867.00 2.49%
SoftBank Corp. Equity 50,923,600 $2,960,164,263.00 2.3%
Novartis AG Equity 29,069,832 $2,874,691,180.00 2.24%
Prudential PLC Equity 89,873,984 $2,225,298,651.00 1.73%
Barclays PLC Equity 594,827,410 $2,134,352,400.00 1.66%
HDFC Bank Ltd. Equity 96,247,659 $1,841,501,010.00 1.43%
Murata Manufacturing Co., Ltd. Equity 12,427,300 $1,712,107,106.00 1.33%
Nintendo Co., Ltd. Equity 11,332,600 $1,667,784,079.00 1.3%
Baidu, Inc., Class A (ADR) Equity 8,002,400 $1,667,700,160.00 1.3%
AIA Group Ltd. Equity 266,353,200 $1,669,369,908.00 1.3%
Associated British Foods PLC Equity 39,095,838 $1,633,352,779.00 1.27%
Toyota Motor Corp. Equity 22,558,800 $1,574,413,825.00 1.23%
Altice SA Equity 14,212,741 $1,534,852,753.00 1.19%
International Consolidated Airlines Group, SA (CDI) Equity 163,039,440 $1,457,486,572.00 1.13%
All Holdings: 1 - 15 of 476

Investors should carefully consider investment objectives, risks, charges and expenses. This and other important information is contained in the fund prospectuses and summary prospectuses, which can be obtained from a financial professional and should be read carefully before investing.

Investments are not FDIC-insured, nor are they deposits of or guaranteed by a bank or any other entity, so they may lose value.

  1. Excludes certain securities in initial period of acquisition.

Investing outside the United States involves risks, such as currency fluctuations, periods of illiquidity and price volatility, as more fully described in the prospectus. These risks may be heightened in connection with investments in developing countries.

For more information about the risks associated with each fund, go to its detailed fund information page or read the prospectus.